Skip to main content
. Author manuscript; available in PMC: 2020 Dec 11.
Published in final edited form as: J Thromb Haemost. 2020 Aug 28;18(11):2899–2909. doi: 10.1111/jth.15037

Table 1:

Comparative effects of FXII and FXI deficiency in mouse venous thrombosis models

Approach Model Phenotype Ref
ASO St Thomas’ Targeting FXII and FXI with high level knockdown equally protective 18
KO IVC stenosis FXII deficiency, but not FXI deficiency, protective 19
siRNA FVEI Targeting FXII more protective than FXI for intermediate level knockdown 61
KO IVC stenosis FXII and FXI deficiency equally protective Current Study
KO IVC stasis FXII and FXI deficiency not protective Current Study
KO FVEI FXII and FXI deficiency equally protective Current Study

antisense oligonucleotide, ASO; inferior vena cava, IVC; short interfering RNA, siRNA, femoral vein electrolytic injury, FVEI; knockout, KO